Filing metadata

Accession number
0001209191-22-025469
Form type
Form 4
Filer
Fusion Pharmaceuticals Inc.
CIK
CIK 1805890
Filed
Apr 22, 2022
Reporting period
Apr 20, 2022
Description
Insider transaction

Explore SEC Filings Hub